Par Drugs and Chemicals Limited

NSEI:PAR Rapporto sulle azioni

Cap. di mercato: ₹3.0b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Par Drugs and Chemicals Gestione

Gestione criteri di controllo 3/4

Par Drugs and Chemicals' Il CEO è Jignesh Savani, nominato in Nov2018, e ha un mandato di 5.83 anni. la retribuzione annua totale è ₹ 5.19M, composta da 99.3% di stipendio e 0.7% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 42.36% delle azioni della società, per un valore di ₹ 1.30B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 5.8 anni e 6.1 anni.

Informazioni chiave

Jignesh Savani

Amministratore delegato

₹5.2m

Compenso totale

Percentuale dello stipendio del CEO99.3%
Mandato del CEO5.8yrs
Proprietà del CEO42.4%
Durata media del management5.8yrs
Durata media del Consiglio di amministrazione6.1yrs

Aggiornamenti recenti sulla gestione

Recent updates

Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Apr 16
Improved Earnings Required Before Par Drugs and Chemicals Limited (NSE:PAR) Stock's 29% Jump Looks Justified

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Apr 05
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

Nov 03
Do Par Drugs and Chemicals' (NSE:PAR) Earnings Warrant Your Attention?

If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

May 19
If EPS Growth Is Important To You, Par Drugs and Chemicals (NSE:PAR) Presents An Opportunity

Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Mar 17
Does Par Drugs and Chemicals (NSE:PAR) Deserve A Spot On Your Watchlist?

Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Oct 22
Do Par Drugs and Chemicals's (NSE:PAR) Earnings Warrant Your Attention?

Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Aug 11
Investors Shouldn't Be Too Comfortable With Par Drugs and Chemicals' (NSE:PAR) Robust Earnings

Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Jul 14
Here's Why We Think Par Drugs and Chemicals (NSE:PAR) Is Well Worth Watching

Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Mar 31
Is Par Drugs and Chemicals Limited (NSE:PAR) An Attractive Dividend Stock?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Mar 05
Are Strong Financial Prospects The Force That Is Driving The Momentum In Par Drugs and Chemicals Limited's NSE:PAR) Stock?

Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Feb 06
Chairman of the Board & MD Falgun Savani Just Bought A Handful Of Shares In Par Drugs and Chemicals Limited (NSE:PAR)

Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

Jan 10
Here's Why I Think Par Drugs and Chemicals (NSE:PAR) Might Deserve Your Attention Today

How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Dec 13
How Does Par Drugs and Chemicals Limited (NSE:PAR) Fare As A Dividend Stock?

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Jignesh Savani rispetto agli utili di Par Drugs and Chemicals?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

₹146m

Mar 31 2024₹5m₹5m

₹145m

Dec 31 2023n/an/a

₹142m

Sep 30 2023n/an/a

₹127m

Jun 30 2023n/an/a

₹115m

Mar 31 2023₹5mn/a

₹113m

Dec 31 2022n/an/a

₹103m

Sep 30 2022n/an/a

₹106m

Jun 30 2022n/an/a

₹91m

Mar 31 2022₹5m₹5m

₹92m

Dec 31 2021n/an/a

₹112m

Sep 30 2021n/an/a

₹112m

Jun 30 2021n/an/a

₹115m

Mar 31 2021₹4m₹4m

₹116m

Dec 31 2020n/an/a

₹88m

Sep 30 2020n/an/a

₹83m

Jun 30 2020n/an/a

₹65m

Mar 31 2020₹4mn/a

₹48m

Compensazione vs Mercato: La retribuzione totale di Jignesh ($USD 61.77K ) è superiore alla media delle aziende di dimensioni simili nel mercato Indian ($USD 37.56K ).

Compensazione vs guadagni: La retribuzione di Jignesh è stata coerente con le performance aziendali dell'ultimo anno.

AMMINISTRATORE DELEGATO

Jignesh Savani (47 yo)

5.8yrs

Mandato

₹5,185,000

Compensazione

Mr. Jignesh Vallabhbhai Savani is Promoter of at Par Drugs and Chemicals Limited and has been its Chief Executive Officer since November 26, 2018 and serves as its Executive Director since February 26, 199...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Falgun Savani
Chairman of the Board & MD25.6yrs₹5.21m21.5%
₹ 640.7m
Jignesh Savani
CEO & Executive Director5.8yrs₹5.19m42.36%
₹ 1.3b
Chintan Chauhan
Chief Financial Officer5.8yrs₹589.00kNessun dato
Sanket Trivedi
Company Secretary & Compliance Officer6yrs₹663.00kNessun dato
Ghanshayambhai Savani
Whole Time Director5.8yrs₹5.18m6.52%
₹ 194.3m

5.8yrs

Durata media

47yo

Età media

Gestione esperta: Il team dirigenziale di PAR è esperto e expertise (durata media dell'incarico 5.8 anni).

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Falgun Savani
Chairman of the Board & MD25.6yrs₹5.21m21.5%
₹ 640.7m
Jignesh Savani
CEO & Executive Director25.6yrs₹5.19m42.36%
₹ 1.3b
Ghanshayambhai Savani
Whole Time Director12.4yrs₹5.18m6.52%
₹ 194.3m
Pravin Bhayani
Lead Independent Director5.7yrs₹1.29mNessun dato
Kajal Vaghani
Independent Director5.7yrs₹40.00kNessun dato
Krishna Shah
Independent Director5.7yrs₹90.00kNessun dato
Nayna Savani
Non Executive Director6.6yrs₹50.00k1.54%
₹ 45.9m
Bintal Bhaveshkumar Shah
Independent Director4yrs₹25.00kNessun dato

6.1yrs

Durata media

47.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di PAR sono considerati esperti (durata media dell'incarico 6 anni).